SCHEMBL4174543

SCHEMBL4174543

Cc1ccc(Oc2ccnc(Nc3ccc(S(C)(=O)=O)cc3)c2)c(C)n1

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 19/20 0.82
IKBKB O14920 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29429424 0.90 TGFBR1 (1.00) TGFBR1
SCHEMBL29657184 0.90 TGFBR1 (1.00) TGFBR1
SCHEMBL373618 0.90 TGFBR1 (1.00) TGFBR1
SCHEMBL4172942 0.89 TGFBR1 (0.79) TGFBR1
SCHEMBL4168353 0.88 TGFBR1 (0.77) TGFBR1
SCHEMBL4183440 0.86 TGFBR1 (0.73) TGFBR1
SCHEMBL3946083 0.86 TGFBR1 (0.73) TGFBR1
SCHEMBL4177354 0.85 TGFBR1 (0.72) TGFBR1
SCHEMBL4170271 0.84 TGFBR1 (0.71) TGFBR1
SCHEMBL4170371 0.84 TGFBR1 (0.71) TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048269-A1 CHEMICAL COMPOUNDS-821 ASTRAZENECA AB (SE) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048269-A1 CHEMICAL COMPOUNDS-821 TGFBR1, TGFBR2, SMAD3 TGFBR1 1/4885IKBKB 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.